Advanced HER2-positive Breast Cancer or Gastric Cancer Completed Phase 1 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0057957 (Advanced HER2-positive Breast Cancer or Gastric Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01602406Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric CancerTreatment